---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

<sup>*</sup> indicates equal contributions.

## Refereed Journal Publications
1. **Xu Y**, Zeng D, Lin DY. (2023). Proportional rates models for multivariate panel count data. **Biometrics**, accepted. [An earlier version of this manuscript won the **2023 ASA Lifetime Data Science (LiDS) Section Student Paper Award** and the **2024 ENAR Distinguished Student Paper Award**]
2. Lin DY, **Xu Y**, Zeng D, Sunny SK. (2023). [A Cost-Benefit Analysis of Bivalent Covid-19 Vaccines](https://www.fortunejournals.com/articles/a-costbenefit-analysis-of-bivalent-covid19-vaccines.html). **Journal of Biotechnology and Biomedicine** 6(4), 551–553.
3. Lin DY<sup>*</sup>, **Xu Y**<sup>*</sup>, Gu Y<sup>*</sup>, Zeng D, Wheeler B, Young H, Sunny SK, Moore Z. (2023). [Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on Omicron infection and severe outcomes in children under 12 years of age: an observational cohort study](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00272-4/fulltext). **The Lancet Infectious Diseases** 23(11), 1257–1265. \[[News](https://www.altmetric.com/details/150195124/news?src=bookmarklet)\]
4. Lin DY, **Xu Y**, Gu Y, Zeng D, Sunny SK, Moore Z. (2023). [Durability of bivalent boosters against Omicron subvariants](https://www.nejm.org/doi/full/10.1056/NEJMc2302462). **New England Journal of Medicine** 388(19), 1818–1820. \[[News](https://www.altmetric.com/details/145643558/news?src=bookmarklet)\]
5. Lin DY, **Xu Y**, Gu Y, Zeng D, Wheeler B, Young H, Sunny SK, Moore Z. (2023). [Effectiveness of bivalent boosters against severe Omicron infection](https://www.nejm.org/doi/full/10.1056/NEJMc2215471). **New England Journal of Medicine** 388(8), 764–766. \[[News](https://www.altmetric.com/details/141787740/news?src=bookmarklet)\]
6. **Xu Y**, Zeng D, Lin DY. (2022). [Marginal proportional hazards models for multivariate interval-censored data](https://academic.oup.com/biomet/article-abstract/110/3/815/6794202). **Biometrika** 110, 815–830.
7. Lin DY, Gu Y, **Xu Y**, Wheeler B, Young H, Sunny SK, Moore Z, Zeng D. (2022). [Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes](https://jamanetwork.com/journals/jama/article-abstract/2796893). **JAMA** 328(14), 1415–1426. \[[News](https://www.altmetric.com/details/136446237/news?src=bookmarklet)\]
8. Lin DY, Gu Y, **Xu Y**, Zeng D, Wheeler B, Young H, Sunny SK, Moore Z. (2022). [Effects of vaccination and previous infection on Omicron infections in children](https://www.nejm.org/doi/full/10.1056/NEJMc2209371). **New England Journal of Medicine** 387(12), 1141–1143. \[[News](https://www.altmetric.com/details/135646402/news?src=bookmarklet)\]

## Under Review
1. Lin DY<sup>*</sup>, **Xu Y**<sup>*</sup>, Gu Y, Sunny SK, Moore Z, Zeng D. (2023+). Impact of booster vaccination interval on SARS-CoV-2 infection, hospitalization, and death.
2. Paritala S, **Xu Y**, Du Y, Donahue M, Maloney P, Lin DY. (2023+). [Effectiveness of Bivalent Boosters Over Nine and Half Months in Nebraska](https://www.medrxiv.org/content/10.1101/2023.12.03.23299338v1).

## In Preparation
1. **Xu Y**, Zeng D, Lin DY. (2023+). Model checking techniques for the Cox proportional hazards models under interval censoring.
2. Lin DY, Du Y, **Xu Y**, Paritala S, Donahue M, Maloney P. (2023+). Effectiveness of XBB.1.5 Vaccines Against Omicron Subvariants.
